Trials of adult stem cells are more common than embryonic research

08/2/2010 | Los Angeles Times (tiered subscription model)

The use of adult stem cells in clinical trials for the treatment of multiple sclerosis, blood diseases and other conditions has become more prevalent than embryonic stem cell studies because of the ethical debate surrounding embryo-derived cells. Although embryonic stem cells hold promise for the development of replacement tissues, such cells are more likely to be used in the near term as laboratory tools for identifying therapeutic compounds and studying the origins of diseases.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC